Reversible DNA Hypermethylation of the Interleukin-15 (IL-15) Promoter Induces IL-15 Expression, Drives the Pathogenesis of T-Cell Large Granular Lymphocytic Leukemia and Provides a Potential Therapeutic Approach Using 5-Azacitidine - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Communication Dans Un Congrès Année : 2019

Reversible DNA Hypermethylation of the Interleukin-15 (IL-15) Promoter Induces IL-15 Expression, Drives the Pathogenesis of T-Cell Large Granular Lymphocytic Leukemia and Provides a Potential Therapeutic Approach Using 5-Azacitidine

Domaines

Immunologie Cancer

Dates et versions

inserm-02991752 , version 1 (06-11-2020)

Identifiants

Citer

Jonathan Brammer, Amy Boles, Anthony Mansour, Aharon Freud, Monique Mathé-Allainmat, et al.. Reversible DNA Hypermethylation of the Interleukin-15 (IL-15) Promoter Induces IL-15 Expression, Drives the Pathogenesis of T-Cell Large Granular Lymphocytic Leukemia and Provides a Potential Therapeutic Approach Using 5-Azacitidine. 61th ASH Annual Meeting, Dec 2019, Orlando, Florida, United States. pp.3776-3776, ⟨10.1182/blood-2019-131174⟩. ⟨inserm-02991752⟩
25 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More